The Carter review, published on 5 February 2016, indicated that substantial cost savings can be made across hospitals and hospital pharmacy services. As part of the ongoing work of the review, the NHS has used benchmarking exercises to compare hospital services and identify potential efficiency savings. The identified cost savings for the Hospital Pharmacy Medicines Optimisation (HoPMOp) project are £800m by 2020. In the three years leading up to then, the NHS will spend E23bn on medicines (conservatively based on a 15% annual increase), so E800m represents a saving of around 3.4%.
展开▼